...
首页> 外文期刊>Journal of biomedical materials research. Part B, Applied biomaterials. >Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo in vivo
【24h】

Bone morphogenic protein expression and bone formation are induced by bioactive glass S53P4 scaffolds in vivo in vivo

机译:通过体内体内体内生物活性玻璃S53P4支架诱导骨形态发生蛋白表达和骨形成

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

Abstract The two‐stage induced‐membrane (IM) technique is increasingly used for treatment of large bone defects. In stage one, the bone defect is filled with polymethylmethacrylate (PMMA), which induces a membrane around the implant. In stage two, PMMA is replaced with bone graft. Bioactive glasses (BAGs) are bone substitutes with bone‐stimulating and angiogenic properties. We have previously shown that a certain type of BAG can also induce a foreign‐body membrane similar to PMMA. The aim of this study was to evaluate the bone‐forming capacity of sintered BAG‐S53P4 and poly(lactide‐ co ‐glycolide) (PLGA)‐coated BAG‐S53P4 scaffolds for potential use as bone substitutes in a single‐stage IM technique. Sintered porous rods of BAG‐S53P4, BAG‐S53P4‐PLGA, or PMMA were implanted in rabbit femurs for 2, 4, or 8?weeks. The expression of bone morphogenic protein (BMP)‐2, ‐4, and ‐7 in the IMs of implanted materials were analyzed with real‐time quantitative polymerase chain reaction. Micro‐computed tomography imaging was used to evaluate bone growth and further verified with scanning electron microscopy. BAG‐S53P4 and BAG‐S53P4‐PGLA scaffold IMs show similar or superior expression of BMP‐2, ‐4, and ‐7 compared with PMMA IM. Bone ingrowth into BAG scaffolds increased over time. Active bone formation occurred inside the BAG scaffolds and the respective BMP expressions were similar or superior for the BAG IMs compared with PMMA, thus making BAGs a promising device for single‐stage treatment of bone defects. ? 2018 Wiley Periodicals, Inc. J Biomed Mater Res B Part B: Appl Biomater, 2018. ? 2018 Wiley Periodicals, Inc. J Biomed Mater Res Part B: Appl Biomater 107B: 847–857, 2019.
机译:摘要两阶段诱导膜(IM)技术越来越多地用于治疗大骨缺陷。在第一阶段,骨缺损填充有聚甲基丙烯酸甲酯(PMMA),其在植入物周围诱导膜。在第二阶段,PMMA被骨移植物代替。生物活性玻璃(袋)是骨替代骨刺激和血管生成性能的骨代替。我们之前已经表明,某种类型的袋子也可以诱导类似于PMMA的异物膜。本研究的目的是评估烧结袋-S53P4和聚(Lactide-Co-Co-Glycoride)(PLGA)涂层袋-S53P4支架的骨形成能力,用于在单级IM技术中作为骨代替氏素。袋-S53P4,袋-S53P4-PLGA或PMMA的烧结多孔棒植入兔股骨中2,4或8个周。用实时定量聚合酶链式反应分析骨形态发生蛋白(BMP)-2,-4和-7中的骨形态发生蛋白(BMP)-2,-4和-7。微计算机断层摄影成像用于评估骨生长并进一步用扫描电子显微镜进行验证。 BAG-S53P4和BAG-S53P4-PGLA脚手架IMS显示与PMMA IM相比的BMP-2,-4和-7的类似或优越的表达。骨头向袋脚手架随着时间的推移而增加。在袋子支架内发生活性骨形成,与PMMA相比,袋IMS相似或优于袋IM,从而使袋子成为骨缺损的单阶段治疗的有希望的装置。还2018 Wiley期刊,Inc。J生物密制Res B部分B:苹果生物摩特,2018年。? 2018 Wiley期刊,INC.J生物保解率A部分B:苹果生物用法物品107B:847-857,2019。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号